Waters BioAccord LC-MS System with ACQUITY Premier

Overview

The Waters BioAccord LC-MS System with ACQUITY Premier is a purpose-built, integrated liquid chromatography–mass spectrometry platform engineered for biopharmaceutical characterization and quality control laboratories operating under regulated environments. It combines the high-resolution, accurate-mass performance of a time-of-flight (TOF) mass spectrometer with the robust, low-dead-volume chromatographic separation power of the ACQUITY Premier UPLC system—specifically optimized to minimize analyte-surface interactions. The system operates on the principle of electrospray ionization (ESI) coupled with orthogonal acceleration TOF mass analysis, delivering consistent mass accuracy (< 5 ppm RMS), high dynamic range, and reproducible detection across diverse biomolecules including intact proteins, subunits, oligonucleotides, mRNA fragments, and post-translational modification variants. Designed from the ground up for compliance-driven workflows, it supports end-to-end data integrity—from acquisition through processing to reporting—within a single relational database architecture.

Key Features

• ACQUITY Premier UPLC Technology: Utilizes MaxPeak High Performance Surface (HPS) hardware throughout fluidic pathways to suppress metal- and silanol-mediated adsorption, significantly improving recovery of acidic glycans, lipids, phosphopeptides, and metal-sensitive oligonucleotides.
• Time-of-Flight Mass Spectrometer: Delivers high mass accuracy, resolution (> 30,000 FWHM at m/z 1,000), and sensitivity for both intact mass analysis and peptide mapping applications without compromising throughput.
• UNIFI Scientific Information System: A unified, audit-trail-enabled software platform compliant with FDA 21 CFR Part 11, supporting electronic signatures, role-based access control, and configurable user permissions.
• Pre-validated Installation Qualification (IQ) and Operational Qualification (OQ) protocols: Includes application-specific system suitability tests aligned with ICH Q5E and USP guidelines for biomolecular characterization.
• Automated Data Processing Workflows: Preconfigured methods for intact mass analysis, peptide mapping, glycan profiling, free N-glycan analysis, and multi-attribute monitoring (MAM) reduce manual intervention and method development time.

Sample Compatibility & Compliance

The BioAccord LC-MS system demonstrates broad compatibility with complex biopharmaceutical samples—including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), fusion proteins, bispecifics, oligonucleotide therapeutics (ASOs, siRNAs), and mRNA constructs. Its surface-passivated flow path ensures minimal non-specific binding, enabling reliable quantitation of low-abundance variants and modifications. From a regulatory standpoint, the system supports GLP and GMP-compliant operations through full traceability: every raw data file, processing step, parameter change, and report generation event is captured in an immutable audit trail. All software modules undergo periodic security validation and are compatible with enterprise-level IT infrastructure, including network authentication (LDAP/Active Directory integration) and encrypted data storage.

Software & Data Management

UNIFI serves as the central scientific information management system, unifying instrument control, data acquisition, processing, review, and reporting within one validated environment. It features built-in compliance tools such as electronic signatures, automated backup scheduling, and granular permission settings (e.g., analyst, reviewer, administrator). All processing methods—including deconvolution algorithms for intact mass, retention time alignment for peptide maps, and relative quantitation modules for impurity profiling—are version-controlled and exportable for cross-laboratory harmonization. Raw data files adhere to open standards (e.g., mzML) and can be archived in long-term storage systems compliant with ISO/IEC 27001 and 21 CFR Part 11 Annex 11 requirements.

Applications

• Intact and subunit mass analysis for primary structure confirmation and higher-order structural assessment
• Peptide mapping and multi-attribute monitoring (MAM) for process consistency evaluation and comparability studies
• Free N-glycan profiling using enzymatic release and HILIC-UPLC separation
• Impurity identification and quantitation—including deamidation, oxidation, truncations, and sequence variants—in stability-indicating assays
• Oligonucleotide purity and modification analysis without column passivation or extended equilibration
• mRNA fragment characterization, including cap structure verification and poly(A) tail length distribution

FAQ

Is the BioAccord LC-MS system compliant with FDA 21 CFR Part 11?
Yes—the UNIFI software provides full electronic signature support, audit trail functionality, and role-based access control required for Part 11 compliance.
Can the system perform both intact protein analysis and bottom-up peptide mapping?
Yes—it supports dual-mode operation: high-mass transmission for intact analysis and optimized fragmentation conditions for peptide-level characterization.
What level of mass accuracy and resolution does the TOF detector deliver?
Typical mass accuracy is < 5 ppm RMS over a 48-hour run; resolution exceeds 30,000 FWHM at m/z 1,000 under standard operating conditions.
Does Waters provide installation qualification (IQ) and operational qualification (OQ) documentation?
Yes—pre-validated IQ/OQ protocols and application-specific system suitability tests are included with the system and supported by Waters Field Service Engineers.
Is UNIFI compatible with LIMS integration?
Yes—UNIFI offers RESTful API endpoints and supports common laboratory informatics standards (e.g., ASTM E1578, HL7) for bidirectional LIMS communication.